Guilin Sanjin Pharmaceutical Co Ltd (002275) - Total Liabilities

Latest as of September 2025: CN¥1.05 Billion CNY ≈ $154.36 Million USD

Based on the latest financial reports, Guilin Sanjin Pharmaceutical Co Ltd (002275) has total liabilities worth CN¥1.05 Billion CNY (≈ $154.36 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Guilin Sanjin Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.

Guilin Sanjin Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)

This chart illustrates how Guilin Sanjin Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Guilin Sanjin Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Guilin Sanjin Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guilin Sanjin Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
PLAYTIKA HOLDING DL-01 F:8II	Germany	€4.13 Billion
RITES Limited NSE:RITES	India	Rs33.18 Billion
Fras-le S.A SA:FRAS3	Brazil	R$4.46 Billion
Yeni Gimat Gayrimenkul Yatirim Ortakligi AS IS:YGGYO	Turkey	TL5.98 Billion
thyssenkrupp nucera AG & Co. KGaA XETRA:NCH2	Germany	€384.00 Million
Banpu Power Public Company Limited BK:BPP	Thailand	฿41.44 Billion
SANOFI CONS HEALTHC IND L NSE:SANOFICONR	India	Rs1.63 Billion
Lanzhou LS Heavy Equipment Co SHG:603169	China	CN¥9.62 Billion

Liability Composition Analysis (2006–2024)

This chart breaks down Guilin Sanjin Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Guilin Sanjin Pharmaceutical Co Ltd (002275) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.13	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guilin Sanjin Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual total liabilities of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.22 Billion ≈ $178.88 Million	+9.24%
2023-12-31	CN¥1.12 Billion ≈ $163.76 Million	-2.82%
2022-12-31	CN¥1.15 Billion ≈ $168.51 Million	-8.32%
2021-12-31	CN¥1.26 Billion ≈ $183.80 Million	+36.04%
2020-12-31	CN¥923.27 Million ≈ $135.10 Million	+53.83%
2019-12-31	CN¥600.18 Million ≈ $87.83 Million	+0.12%
2018-12-31	CN¥599.47 Million ≈ $87.72 Million	+4.14%
2017-12-31	CN¥575.65 Million ≈ $84.24 Million	+29.58%
2016-12-31	CN¥444.26 Million ≈ $65.01 Million	+6.64%
2015-12-31	CN¥416.59 Million ≈ $60.96 Million	-10.04%
2014-12-31	CN¥463.07 Million ≈ $67.76 Million	-4.74%
2013-12-31	CN¥486.11 Million ≈ $71.13 Million	+19.36%
2012-12-31	CN¥407.26 Million ≈ $59.60 Million	+86.67%
2011-12-31	CN¥218.18 Million ≈ $31.93 Million	+20.23%
2010-12-31	CN¥181.47 Million ≈ $26.56 Million	-34.96%
2009-12-31	CN¥279.00 Million ≈ $40.83 Million	-26.32%
2008-12-31	CN¥378.65 Million ≈ $55.41 Million	+8.32%
2007-12-31	CN¥349.58 Million ≈ $51.15 Million	+70.96%
2006-12-31	CN¥204.48 Million ≈ $29.92 Million	--

About Guilin Sanjin Pharmaceutical Co Ltd

SHE:002275 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.14 Billion

CN¥7.79 Billion CNY

Market Cap Rank

#8219 Global

#1845 in China

Share Price

CN¥13.26

Change (1 day)

-1.63%

52-Week Range

CN¥12.08 - CN¥17.38

All Time High

CN¥19.61